The perfusion bioreactor market will see a propensity for digitized integration at a CAGR of 7.5% over the period 2021-2

Posted by Archit Sanjay on June 28th, 2022

The perfusion bioreactor market is likely  to  grow voraciously, at a  CAGR of 7.5%  between 2021 and 2031. Augmented and virtual reality are keeping pace with advanced technologies significantly. VR and AR have great offering potential in the healthcare sector. Areas of application include surgical simulation and training and patient care and treatment.

For medical research, cell culture media are required, which makes in vitro biological tests possible thanks to cell culture. This creates demand for perfusion bioreactors. Growing sources of R&D spending in this area include government funding, private funding, and funding from commercial organizations.

Applied and basic research is the main focus of academic research institutes, where governments and industrial organizations prefer cost-effective methods for production and development. Investments in research and development are expected to increase in all countries of the world in the coming years, particularly in China, India and Brazil, which will drive demand for perfusion bioreactors.

The global perfusion bioreactor market was valued at around  US $ 300 million  in 2020 and is expected to show a  CAGR of approximately 7.5%  over the forecast period (2021-2031).

Get a Sample Copy of this Report @  https://www.persistencemarketresearch.com/samples/14398

Company profiles:

  • Sartorio AG
  • Cell Culture Society
  • Cytiva (Danaher Corporation)
  • CELLEC BIOTEK AG
  • Synthecon Inc
  • Getinge (Applikon Biotechnology BV)
  • Zellwerk GmbH
  • Thermo Fisher Scientific Inc

Methodology Request @  https://www.persistencemarketresearch.com/methodology/14398

Key points of the market study

  • Small-scale bioreactors (<or = 1,000 liters) hold a value share of approximately 64.4%, globally, thanks to technological advances in bioreactors.
  • Raising awareness of good manufacturing practices and R&D funding is giving the market a boost.
  • In terms of the end user, biopharmaceutical companies contribute to a large extent to the market due to their high production of cell culture products.
  • The North American region is dominant in the global perfusion bioreactor market and will continue to remain the most profitable market over the forecast period.

"Biopharmaceutical companies are seeing growth in emerging economies and developed countries thanks to effective manufacturing, high research activity and a growing awareness of good manufacturing practices,"  says an analyst with Persistence Market Research.

Impact of COVID-19

The impact of COVID-19 can be easily seen in the financial data of all companies. In the United States, COVID-19 cases have reached 7 million with over 1 million deaths. Due to this unprecedented pandemic scenario, the healthcare sector around the world has been the center of attention.

However, the global perfusion bioreactor market can be said to be minimally affected. The new installations were affected due to hampered import activities and supply chain crises.

Access the full report @  https://www.persistencemarketresearch.com/checkout/14398

Launch of new products - Strategy of the main players

Leading perfusion bioreactor manufacturers use the strategy of introducing new and innovative products based on patient needs. This factor has led to intense competition between market players.

  • For example, in March 2021, Getinge launched a new holistic system approach for the preparation of Applikon's multipurpose bioreactors.

What does the report cover?

Persistence Market Research offers a unique perspective and actionable insights into the perfusion bioreactor market in its latest study, presenting the 2016-2020 historical demand assessment and 2021-2031 projections.

The research study is based on scale (small-scale bioreactors and large-scale bioreactors), application (R&D and GMP) and end-user (biopharmaceutical companies, academic and research institutes, contract research organizations (CROs) and contract manufacturing (CMO)), in seven key regions of the world.

Who we are:

Persistence Market Research (PMR), as a third-party research organization, works through a unique fusion of market and data analytics to help companies rise to the top, in research from the turmoil faced by financial / natural crises.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
US Ph. - + 1-646-568-7751
USA-Canada Toll Free - +1 800-961-0353
Sales  - sales @ persistencemarketresearch
Site web .com - https://www.persistencemarketresearch.com

Like it? Share it!


Archit Sanjay

About the Author

Archit Sanjay
Joined: April 12th, 2021
Articles Posted: 390

More by this author